-
Je něco špatně v tomto záznamu ?
Venous thromboembolism - prevalence and risk factors in chronic venous disease patients
D. Musil, M. Kaletová, J. Herman,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, pozorovací studie
PubMed
26911618
DOI
10.1177/0268355516633392
Knihovny.cz E-zdroje
- MeSH
- chronická nemoc MeSH
- dospělí MeSH
- estrogeny aplikace a dávkování škodlivé účinky MeSH
- hormonální substituční terapie MeSH
- kouření škodlivé účinky epidemiologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- obezita epidemiologie patofyziologie MeSH
- prevalence MeSH
- retrospektivní studie MeSH
- rizikové faktory MeSH
- žilní tromboembolie epidemiologie patofyziologie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- pozorovací studie MeSH
Aims This study was aimed to investigate the prevalence of venous thromboembolism in patients with chronic venous disease and the impact of some intrinsic and extrinsic risk factors. Methods A retrospective study on 641 outpatients (489 women) with primary chronic venous disease (C0-C6). The prevalence of venous thromboembolism was evaluated according to sex, age, BMI, the presence of ≥1 first-degree siblings diagnosed with venous thromboembolism, CEAP clinical class, smoking and the use of hormone therapy. Results Venous thromboembolism episodes occurred in 32 patients (5%) with no gender predominance (OR 1.49, 95% CI = 0.90-2.45; p = 0.146). There was no increased RR of venous thromboembolism in the age group 46-69 years compared with patients aged ≤45 years ( p = 0.350). In persons aged ≥70 years, the risk of venous thromboembolism was 3.2 times higher than in patients aged 46-69 years and 4.78 times higher than in patients aged ≤45 years. The risk of venous thromboembolism rose very significantly in obese compared with normostenic patients ( p = 0.002). There were significantly more venous thromboembolism episodes in patients with chronic venous insufficiency (55.3%) than patients with varicose veins (44.7%) ( p < 0.001). A family history of venous thromboembolism ( p = 0.12), smoking ( p = 0.905) and hormone therapy ( p = 0.326) were not associated with increased risk of venous thromboembolism. Smoking was a risk factor in obese patients ( p = 0.033), but the combination of obesity, smoking, estrogens in women did not increase the risk of venous thromboembolism. Conclusions The 5% prevalence of venous thromboembolism episodes in patients was comparable with the prevalence of venous thromboembolism in the general European population. Age ≥70 years and obesity were strongly associated with an occurrence of venous thromboembolism. Obese patients with chronic venous disease were at higher risk for venous thromboembolism than obese people in the general population. A family history of venous thromboembolism, smoking and estrogens alone or in combination were not revealed as significant risk factors.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18034139
- 003
- CZ-PrNML
- 005
- 20181012102440.0
- 007
- ta
- 008
- 181008s2017 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1177/0268355516633392 $2 doi
- 035 __
- $a (PubMed)26911618
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Musil, Dalibor $u 1 Department of Internal Medicine I - Cardiology, Teaching Hospital, Olomouc, Czech Republic.
- 245 10
- $a Venous thromboembolism - prevalence and risk factors in chronic venous disease patients / $c D. Musil, M. Kaletová, J. Herman,
- 520 9_
- $a Aims This study was aimed to investigate the prevalence of venous thromboembolism in patients with chronic venous disease and the impact of some intrinsic and extrinsic risk factors. Methods A retrospective study on 641 outpatients (489 women) with primary chronic venous disease (C0-C6). The prevalence of venous thromboembolism was evaluated according to sex, age, BMI, the presence of ≥1 first-degree siblings diagnosed with venous thromboembolism, CEAP clinical class, smoking and the use of hormone therapy. Results Venous thromboembolism episodes occurred in 32 patients (5%) with no gender predominance (OR 1.49, 95% CI = 0.90-2.45; p = 0.146). There was no increased RR of venous thromboembolism in the age group 46-69 years compared with patients aged ≤45 years ( p = 0.350). In persons aged ≥70 years, the risk of venous thromboembolism was 3.2 times higher than in patients aged 46-69 years and 4.78 times higher than in patients aged ≤45 years. The risk of venous thromboembolism rose very significantly in obese compared with normostenic patients ( p = 0.002). There were significantly more venous thromboembolism episodes in patients with chronic venous insufficiency (55.3%) than patients with varicose veins (44.7%) ( p < 0.001). A family history of venous thromboembolism ( p = 0.12), smoking ( p = 0.905) and hormone therapy ( p = 0.326) were not associated with increased risk of venous thromboembolism. Smoking was a risk factor in obese patients ( p = 0.033), but the combination of obesity, smoking, estrogens in women did not increase the risk of venous thromboembolism. Conclusions The 5% prevalence of venous thromboembolism episodes in patients was comparable with the prevalence of venous thromboembolism in the general European population. Age ≥70 years and obesity were strongly associated with an occurrence of venous thromboembolism. Obese patients with chronic venous disease were at higher risk for venous thromboembolism than obese people in the general population. A family history of venous thromboembolism, smoking and estrogens alone or in combination were not revealed as significant risk factors.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a chronická nemoc $7 D002908
- 650 _2
- $a estrogeny $x aplikace a dávkování $x škodlivé účinky $7 D004967
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a hormonální substituční terapie $7 D020249
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a obezita $x epidemiologie $x patofyziologie $7 D009765
- 650 _2
- $a prevalence $7 D015995
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a kouření $x škodlivé účinky $x epidemiologie $7 D012907
- 650 _2
- $a žilní tromboembolie $x epidemiologie $x patofyziologie $7 D054556
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a pozorovací studie $7 D064888
- 700 1_
- $a Kaletová, Markéta $u 1 Department of Internal Medicine I - Cardiology, Teaching Hospital, Olomouc, Czech Republic.
- 700 1_
- $a Herman, Jiří $u 2 Department of Surgery II - Vascular and Transplantation Surgery, Teaching Hospital, Olomouc, Czech Republic.
- 773 0_
- $w MED00003815 $t Phlebology $x 1758-1125 $g Roč. 32, č. 2 (2017), s. 135-140
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26911618 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20181008 $b ABA008
- 991 __
- $a 20181012102932 $b ABA008
- 999 __
- $a ok $b bmc $g 1340459 $s 1031133
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 32 $c 2 $d 135-140 $e 20160709 $i 1758-1125 $m Phlebology $n Phlebology $x MED00003815
- LZP __
- $a Pubmed-20181008